United States · FDA National Drug Code directory
IXIARO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42515-002_f3d13c93-5fce-43db-b25f-8e1c8cd1dfb8
- Product NDC
- 42515-002
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Japanese Encephalitis Vaccine, Inactivated, Adsorbed
- Labeler
- Valneva Scotland Ltd.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20090330
- Source listing expiry
- 20261231
Source-listed ingredients
- JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED) — 6 [arb'U]/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- .5 mL in 1 SYRINGE (42515-002-01) · 42515-002-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →